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Inherited retinal dystrophies (IRDs) are a group of 
disorders characterized by retinal degeneration with changes 
in the rod or cone photoreceptors. There are currently 301 
genes and loci reported for IRD (RetNet), making molecular 
diagnosis challenging. Retinitis pigmentosa (RP, OMIM 
268000) is the most common cause of IRD with a prevalence 
of 1/3,000 to 1/5,000 people among different populations 
[1,2]. RP is characterized by the degeneration of the rod and 
cone photoreceptor cells leading to night blindness, progres-
sive loss of visual fields, and eventually, complete blindness. 
Leber congenital amaurosis (LCA, OMIM 204000) was first 
described in 1869 as a congenital severe form of RP [3]. 
LCA is the most common cause of congenital blindness and 
is characterized by onset in the first 12 months of life with 
severe visual loss, retinal dysfunction, congenital nystagmus, 
and non-recordable electroretinogram. LCA and RP display 
heterogeneous and overlapping clinical phenotypes, 
representing a continuum of phenotype with LCA at the 
severe end and RP at the mild end. Both diseases are geneti-
cally heterogeneous: 25 genes are known to be causative for 
LCA and more than 80 genes for non-syndromic RP (RetNet). 
Variants in several genes, including TULP1, cause overlap-
ping phenotypes involving LCA and RP [4].
Variants in the TULP1 gene (6q21.3, OMIM 602280) 
were first identified in patients with RP [5,6] and were subse-
quently reported in 1–2% of patients with LCA [7]. TULP1 
is a member of the tubby-like protein family and contains 
a highly conserved C-terminal tubby domain. TULP1 is 
expressed exclusively in the photoreceptor cells of the retina 
[8]. TULP1 knockout mice display progressive retinal degen-
eration with rapid loss of photoreceptor cells from 2 weeks of 
age [9]. The protein is involved in the trafficking of rhodopsin 
from its synthesis in the inner segments to the outer segments 
[9] and provides retinoprotection by stimulating phagocy-
tosis of retinal pigment epithelium cells [10]. In this study, 
we report an individual with a clinical phenotype between 
LCA and severe early onset RP on the phenotypic continuum, 
harboring a novel homozygous TULP1 variant arising from 
maternal uniparental isodisomy of chromosome 6.
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Purpose: Inherited retinal dystrophies are a clinically and genetically heterogeneous group of disorders. Molecular 
diagnosis has proven utility for affected individuals. In this study, we report an individual enrolled in the Australian In-
herited Retinal Disease Registry and DNA Bank diagnosed with clinical features overlapping between Leber congenital 
amaurosis and retinitis pigmentosa.
Methods: DNA from the proband was sequenced using a gene panel for inherited retinal disorders, and a single nucleo-
tide polymorphism (SNP) array was conducted to detect the presence of deletions and uniparental disomy.
Results: We identified a novel homozygous variant (c.524dupC, p.(Pro176ThrfsTer7)) in TULP1 resulting from maternal 
uniparental isodisomy of chromosome 6. The patient had clinical features consistent with biallelic pathogenic variants 
in TULP1, including congenital nystagmus, night blindness, non-recordable electroretinogram, mild myopia, and mild 
peripheral pigmentary changes in the fundus.
Conclusions: This is the first report of uniparental disomy 6 and a homozygous variant in TULP1 associated with a 
rod-cone dystrophy. Molecular diagnosis of inherited retinal dystrophies is essential to inform the mode of transmission 
and clinical management, and to identify potential candidates for future gene-specific therapies.
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METHODS
This study was approved by the Sir Charles Gairdner 
Hospital Human Research Ethics Committee (2001–053) 
and was conducted in accordance with the National Health 
and Medical Research Council statement of ethical conduct 
in research involving humans. The study complied with the 
tenets of the Declaration of Helsinki and the Association for 
Research in Vision and Ophthalmology (ARVO) statement 
on human subjects. Informed written consent was obtained. 
An individual with isolated non-syndromic retinal degen-
eration was ascertained with a complete ophthalmologic 
examination, including best-corrected visual acuity, refrac-
tion, fundoscopy, electroretinogram, visual field testing, and 
macular optical coherence tomography.
Genomic DNA was isolated from peripheral venous 
blood and stored as detailed previously [11]. Briefly, blood 
was obtained by venipuncture and collected in EDTA tubes. 
Genomic DNA was isolated from blood leukocytes using 
the QIAsymphony DSP DNA Midi extraction kit (Qiagen, 
Doncaster, Australia) on the QIAsymphony automated nucleic 
acid extraction platform as per manufacturer’s instructions, 
and stored at -40 degrees. DNA sourced from the Austra-
lian Inherited Retinal Disease Registry and DNA Bank was 
subjected to targeted next-generation sequencing using a 
disease-specific IRD next-generation sequencing SmartPanel 
(250 genes) v9 (Casey Eye Institute, Molecular Diagnostics 
Laboratory, Portland, OR) [12]. Variants of interest were 
confirmed with Sanger sequencing. A single nucleotide poly-
morphism (SNP) array (Illumina Infinium CytoSNP-850K 
BeadChip; Scoresby, Australia) was conducted to further 
investigate deletions of the TULP1 gene and uniparental 
disomy (UPD). Identified variants are available in the ClinVar 
database.
RESULTS
The proband was the second child of a non-consanguineous 
couple of Italian background. The pregnancy was marked by 
oligohydramnios and intrauterine growth retardation, and 
the proband was born at 37 weeks gestation by caesarean 
section with Apgar scores of 9 and 10. Birthweight (1640 g), 
length (44 cm), and head circumference (30.5 cm) were all 
below the third percentile. At 3 months, nystagmus, poor 
pupillary constriction to strong light, and retinal pallor were 
noted. Magnetic resonance imaging performed at that time 
was normal. By 17 months of age, the fundi were normal, but 
an electroretinogram was abnormal with reduced responses 
under light-adapted conditions and no response under dark-
adapted conditions. These findings, in addition to poor night 
vision, suggested a diagnosis of rod-cone dystrophy. At 2 1/2 
years old, the patient had mild myopia (−3.0 D in both eyes). 
At her last examination, she was 22 years old and had poor 
night vision and peripheral vision, bilateral visual acuity of 
6/76, mild to moderate attenuation of arterioles, mild periph-
eral bone spicule-like pigmentation in the fundus, and no 
optic disc atrophy (Figure 1). Optical coherence tomography 
showed severe thinning at the macula (Figure 2). Her diag-
nosis was maintained as a rod-cone dystrophy with overlap 
between LCA and RP. There was no presence of cataracts, 
keratoconus, or macular edema. Both parents had normal 
eye examinations with no features of retinal dystrophy. The 
remaining medical and family histories were unremarkable.
A homozygous novel frameshift variant (c.524dupC, 
p.(Pro176ThrfsTer7)) was identified in the TULP1 gene 
(NM_003322.3) in the proband (Figure 3A). This novel 
variant was considered pathogenic due to its frameshifting 
nature, which is predicted to invoke nonsense-mediated decay 
with subsequent abolition of the protein product. Targeted 
sequencing revealed that the mother was heterozygous and 
the father did not carry the variant. SNP array analyses did 
not identify a deletion on the other allele. The genotype of 
the proband and the father were compared: Informative 
SNPs confirmed paternity and demonstrated no paternal 
inheritance of the whole of chromosome 6, confirming 
maternal isodisomy of this entire chromosome (Figure 3B). 
No evidence for mosaicism of trisomy 6 was detected on 
buccal swab.
Addit ional ly, a novel heterozygous var iant 
(c.1267_1656delinsA, p.(Ala423AsnfsTer11)) in the RP1 gene 
(OMIM 603937; NM_006269.1) was identified in the proband 
and her mother. Truncations occurring between codons 264 
and 499 are associated with autosomal recessive RP [13]. 
This is supported by the fact that the proband’s mother does 
not have retinal degeneration. Although it is unlikely to be a 
primary cause of disease, we cannot rule out a contributory 
effect to disease based on the mutation load [14].
DISCUSSION
TULP1 variants have been associated with milder forms 
of LCA [7] and severe juvenile-onset forms of RP [15,16], 
and intrafamilial variable expressivity has been reported 
[16]. Biallelic variants in TULP1 are usually associated with 
congenital nystagmus, a non-recordable electroretinogram, 
relative preservation of visual acuity and visual field in the 
first decade of life, night blindness, myopic refractive errors, 
and peripheral involvement of the retina resembling the early 
aspects of RP [7,16]. Similarly, the individual described in 
this study had congenital nystagmus, night blindness, visual 
Molecular Vision 2018; 24:478-484 <http://www.molvis.org/molvis/v24/478> © 2018 Molecular Vision 
480
Figure 1. Fundus photography 
of the proband. Mild macular 
atrophy (A) with mild peripheral 
bone spicule-like pigmentation 
in the periphery (B) at age 14 
years in comparison with severe 
atrophic macular changes, waxy 
pallor of the optic disc (C), and 
more pronounced peripheral bone 
spicule-like pigmentation in the 
periphery (D) at age 22 years.
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acuity of 6/76 in both eyes at age 22 years, mild myopia, and 
mild peripheral pigmentary changes in the fundus.
UPD is a rare event in which an individual with a diploid 
genome carries either two homologs of a pair of chromosomes 
from one parent (uniparental heterodisomy) or two copies of a 
single chromosome from one parent (uniparental isodisomy) 
[17]. The most common mechanism is trisomic rescue. 
Disease phenotypes can occur as a result of UPD through 
different mechanisms: genomic imprinting, mosaicism, or 
unmasking of autosomal recessive genetic variants with 
both alleles carrying a deleterious variant inherited from one 
parent. Paternal UPD6 is associated with transient neonatal 
diabetes mellitus and is caused by abnormal imprinting of 
PLAGL1 (OMIM 603044; NM_001080951.2) and HYMAI 
(OMIM 606546; NR_002768.2) [18]. In contrast, maternal 
UPD6 is much rarer with only 15 cases reported. There is 
a possible association with intrauterine growth retardation, 
which was noted in the individual on whom we report [19]. 
The underlying mechanism behind intrauterine growth 
retardation is not known. The extent of UPD involvement 
in IRD is unknown, as UPD often goes unnoticed unless 
revealed by genetic investigation of recessive disease [20]. 
UPD has previously been reported in patients with IRD: 
UPD1 in patients with LCA and variants in RPE65 (OMIM 
180069; NM_000329.2) [21], RP without hearing loss and 
variants in USH2A (OMIM 608400; NM_007123.5) [22], 
and Stargardt disease and variants in ABCA4 (OMIM 601691; 
NM_000350.2) [23,24]; UPD2 in patients with RP and vari-
ants in MERTK (OMIM 604705; NM_006343.2) [21] and RP 
and variants in FAM161A (OMIM 613596; NM_001201543.1) 
[25]; UPD6 in a patient with cone dysfunction and variants 
in TULP1 [26]; and UPD14 in a patient with achromatopsia 
and variants in GNAT2 (OMIM 139340; NM_005272.3) [27]. 
This is the first report of a patient with UPD6 and variants in 
TULP1 associated with a rod-cone dystrophy.
Molecular diagnosis in patients with IRD has proven 
clinical utility. The differential diagnosis for LCA/RP can 
be extensive, and an early molecular diagnosis can inform 
whether the IRD is part of a syndrome or a neurometabolic 
disease, and thus, influence clinical management. LCA and 
RP can be inherited in an autosomal dominant or recessive 
manner; therefore, molecular diagnosis allows the provision 
of accurate genetic counseling, including information about 
risk of recurrence and reproductive options. Finally, advances 
in gene-specific therapy and stem cell therapy could lead to 
new therapeutic avenues for patients with IRD, for which 
identification of causative genetic mechanisms will be a 
pivotal prerequisite.
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Figure 2. Optical coherence tomog-
raphy showing severe thinning of 
the macula in both eyes at age 12 
years, as demonstrated by the thick-
ness being less than 1% of normal 
distribution (red) for both eyes.
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Figure 3. Genetic analysis of the 
proband. A: Sanger sequencing 
electropherograms showing (top to 
bottom) TULP1 reference sequence 
(NM_003322.3), paternal elec-
tropherogram showing wild-type 
sequence, maternal electrophe-
rogram revealing heterozygous 
duplication, c.524dupC (arrow), and 
proband electropherogram showing 
homozygous duplication (arrow) 
of the preceding C nucleotide. B: 
Single nucleotide polymorphism 
(SNP) array showing the absence of 
heterozygous calls on chromosome 
6, corresponding to uniparental 
isodisomy.
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